GSK | GSK plc

Healthcare | Drug Manufacturers - General | United Kingdom | NYSE

Index	-	P/E	12.44	EPS (ttm)	2.76	Insider Own	0.20%	Shs Outstand	2.02B	Perf Week	2.26%
Market Cap	69.14B	Forward P/E	8.57	EPS next Y	4.01	Insider Trans	0.00%	Shs Float	1.99B	Perf Month	-6.55%
Income	5.44B	PEG	2.49	EPS next Q	0.84	Inst Own	13.80%	Short Float / Ratio	0.19% / 1.30	Perf Quarter	2.29%
Sales	36.43B	P/S	1.90	EPS this Y	50.50%	Inst Trans	0.62%	Short Interest	3.72M	Perf Half Y	-2.28%
Book/sh	7.31	P/B	4.70	EPS next Y	8.10%	ROA	21.80%	Target Price	40.00	Perf Year	-21.16%
Cash/sh	4.34	P/C	7.91	EPS next 5Y	5.00%	ROE	122.20%	52W Range	28.47 - 45.51	Perf YTD	-2.22%
Dividend	1.39	P/FCF	559.35	EPS past 5Y	9.60%	ROI	18.10%	52W High	-24.51%	Beta	0.69
Dividend %	4.06%	Quick Ratio	0.70	Sales past 5Y	-0.60%	Gross Margin	70.40%	52W Low	20.71%	ATR	0.52
Employees	69400	Current Ratio	1.00	Sales Q/Q	-3.30%	Oper. Margin	21.40%	RSI (14)	40.62	Volatility	1.22% 1.22%
Optionable	Yes	Debt/Eq	1.77	EPS Q/Q	-16.40%	Profit Margin	50.30%	Rel Volume	0.78	Prev Close	34.62
Shortable	Yes	LT Debt/Eq	1.41	Earnings	Apr 26 BMO	Payout	0.00%	Avg Volume	2.86M	Price	34.36
Recom	2.80	SMA20	-2.40%	SMA50	-4.70%	SMA200	0.49%	Volume	2,232,491	Change	-0.75%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-17-23	Upgrade	Deutsche Bank	Hold → Buy
Feb-27-23	Resumed	Goldman	Buy
Jan-03-23	Downgrade	JP Morgan	Neutral → Underweight
Dec-05-22	Downgrade	BofA Securities	Neutral → Underperform
Nov-11-22	Downgrade	UBS	Neutral → Sell
Sep-15-22	Upgrade	Credit Suisse	Underperform → Neutral
Sep-08-22	Downgrade	Jefferies	Buy → Hold	$50.50 → $34
Aug-05-22	Resumed	Morgan Stanley	Equal-Weight
Jul-21-22	Resumed	Citigroup	Neutral
Feb-11-22	Downgrade	DZ Bank	Buy → Hold
Nov-05-21	Upgrade	Barclays	Underweight → Equal Weight
Jun-24-21	Upgrade	Deutsche Bank	Sell → Hold
Mar-23-21	Downgrade	SVB Leerink	Outperform → Mkt Perform
Feb-04-21	Downgrade	Deutsche Bank	Hold → Sell
Jan-20-21	Downgrade	Credit Suisse	Neutral → Underperform
Jan-15-21	Initiated	Deutsche Bank	Hold
Nov-02-20	Upgrade	Liberum	Hold → Buy
Sep-29-20	Initiated	Berenberg	Buy
Feb-12-20	Downgrade	Shore Capital	Hold → Sell
Jan-16-20	Downgrade	Barclays	Equal Weight → Underweight

Show Previous Ratings

Jun-07-23 10:47AM	GSK's Arexvy Gets the Green Light in Europe: First-Ever RSV Vaccine in Europe for Older Adults (Benzinga)
Jun-06-23 11:36AM	FDA Prioritizes GSK's Breakthrough Drug Jemperli for Endometrial Cancer Treatment, a First in Decades (Benzinga)
Jun-02-23 10:23AM	Investors in GSK (LON:GSK) have unfortunately lost 19% over the last year (Simply Wall St.)
Jun-01-23 08:00AM	GSK Announces the COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the US (Business Wire)
May-31-23 05:55PM	UPDATE 2-US FDA approves Pfizer's RSV vaccine (Reuters)
05:51PM	Loading…
05:51PM	US FDA approves Pfizer's RSV vaccine (Reuters)
May-30-23 10:22AM	Why GSKs Emma Walmsley violently rejects the idea of superhero CEOs (Fortune)
May-24-23 07:05AM	Analyst Report: GSK PLC (Argus Research)
06:50AM	Market Digest: MKL, GSK, NFG (Argus Research)
May-18-23 01:50PM	Top Pharmaceutical Stocks for Q2 2023 (Investopedia)
11:00AM	UPDATE 2-US FDA panel backs Pfizer's maternal RSV vaccine for protecting infants (Reuters)
07:25AM	25 Most Prescribed Medication in the World (Insider Monkey)
07:00AM	US FDA advisers to discuss Pfizer's maternal RSV vaccine (Reuters)
May-16-23 05:01PM	BELLUS Health Inc. Calls Special Shareholders Meeting in Connection with GSK Acquisition (Business Wire)
May-15-23 09:49AM	UPDATE 3-US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute (Reuters)
09:45AM	Loading…
09:45AM	US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute (Reuters)
07:50AM	3 Personalized Medicine Stocks to Buy for Long-Time Returns (InvestorPlace)
May-13-23 12:30PM	These 3 Global Drug Stocks Have a Prescription for High Yields (TheStreet.com)
03:23AM	Interested In GSK's (LON:GSK) Upcoming UK£0.14 Dividend? You Have Four Days Left (Simply Wall St.)
May-12-23 03:08PM	GSK's Meningitis Vaccine Candidate: Crushing Clinical Trials or Just Playing Catch-up with Bexsero and Menveo? (Benzinga)
11:47AM	GSK Trims Stake On Consumer Business Spin Off, Raises £804M (Benzinga)
May-11-23 12:14PM	SpringWorks Therapeutics Announces Clinical Data Presentations of Nirogacestat in Combination with BCMA-Directed Therapies at the European Hematology Association 2023 Congress (GlobeNewswire)
10:23AM	The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer (Motley Fool)
07:00AM	SCYNEXIS Announces First Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
May-08-23 08:00AM	GSK plc (LON:GSK) is favoured by institutional owners who hold 82% of the company (Simply Wall St.)
May-04-23 11:58AM	GSKs vaccine against RSV wins FDA approval (Yahoo Finance Video)
12:28AM	PRESS DIGEST- New York Times business news - May 4 (Reuters)
May-03-23 05:38PM	A Shot of Success: GSK's Arexvy Wins FDA Approval, Pioneering RSV Prevention for Older Adults in Multi-Billion Dollar Market (Benzinga)
04:55PM	FDA Approves GSKs RSV Vaccine for Older Adults (The Wall Street Journal)
01:37PM	US FDA Approves GSKs AREXVY, the Worlds First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults (Business Wire)
01:29PM	Loading…
01:29PM	US approves 1st vaccine for RSV after decades of attempts (AP Finance)
01:15PM	UPDATE 3-US FDA approves first RSV vaccine from GSK (Reuters)
May-02-23 03:51PM	Pfizer to shift focus to new products amid decline in COVID sales (Yahoo Finance)
May-01-23 08:20PM	Why the human genome could be healthcares holy grail (Yahoo Finance Video)
11:54AM	23andMe CEO: We see more opportunities in DNA partnerships (Yahoo Finance)
Apr-28-23 04:28AM	15 Best Very Cheap Stocks to Buy Right Now (Insider Monkey)
Apr-26-23 08:17PM	Analyst Report: GSK plc (Morningstar Research)
04:08PM	Analyst Report: GSK plc (Morningstar Research)
09:22AM	GSK Clocks 10% Growth In Q1 Sales Excluding COVID-19 Products, Reaffirms Guidance (Benzinga)
09:00AM	Was This Acquisition a Savvy Play by This Big Pharma Stock? (Motley Fool)
07:05AM	GSK (GSK) Tops Q1 Earnings Estimates (Zacks)
Apr-20-23 02:36PM	Why Shares of Bellus Health Skyrocketed This Week (Motley Fool)
Apr-18-23 12:11PM	GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health (Business Wire)
11:33AM	Why BELLUS Health Stock Is Rocketing Higher Today (Motley Fool)
11:30AM	Elon Musk Says US Intel Agencies Had Access To Twitter DMs, Alibaba's Ant IPO Might Actually See Light, Airbus Pushes Some 2024 Deliveries: Today's Top Stories (Benzinga)
08:18AM	GSK To Strengthen Specialty Medicines and Respiratory Pipeline With $2B BELLUS Health Acquisition (Benzinga)
06:31AM	GSK to Buy Bellus for $2 Billion to Gain Cough Medicine (Bloomberg)
02:19AM	UPDATE 4-GSK bets $2 bln on Bellus cough drug to soothe pipeline fears (Reuters)
Apr-16-23 05:21AM	Is Arrowhead Pharmaceuticals a Buy Now? (Motley Fool)
Apr-13-23 06:35AM	Ghana is the world's first country to approve Oxford's new malaria vaccine (Quartz)
05:52AM	Can Pfizer Beat GSK and Moderna in This $10 Billion Market? (Motley Fool)
Apr-12-23 08:55AM	Best Dividend Stocks: U.K. Pharma Giant GSK Boasts Attractive 5.2% Yield (Investor's Business Daily)
08:55AM	Best Dividend Stocks: British Pharma Giant GSK Boasts Attractive 5.2% Yield (Investor's Business Daily)
Apr-11-23 12:13PM	Why Shares of Adaptimmune Therapeutics Jumped Tuesday (Motley Fool)
10:51AM	12 Best Covid Treatment Stocks to Buy Today (Insider Monkey)
Apr-07-23 11:04AM	12 Cheap Global Stocks to Buy (Insider Monkey)
07:04AM	The 15 Best Teeth Whitening Products of 2023 (Insider Monkey)
Apr-05-23 07:23AM	Companies Facing Carbon Offset Backlash Quietly Fund Their Own Projects (Bloomberg)
Apr-04-23 08:32PM	Analyst Report: GSK plc (Morningstar Research)
Apr-02-23 05:30AM	Could This Move by Johnson & Johnson Equal Billions for Moderna? (Motley Fool)
Mar-31-23 10:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
12:47PM	Texas Judge Obstructs Affordable Act Coverage Mandate For Some Cancer Screenings, Prophylaxis (Benzinga)
Mar-30-23 02:48PM	Biden admin urges Supreme Court to hear 'skinny labels' case between Teva, GSK (Reuters)
02:43PM	Biden admin urges Supreme Court to hear 'skinny labels' case between Teva, GSK (Reuters)
01:12PM	GSK Bets On Scynexis' FDA-Approved Antifungal Drug For Over $500M In Bio Bucks (Benzinga)
10:16AM	Viatris Among Three Companies Licensed To Make GSK/Pfizer-Backed Long Acting HIV Prevention Drug (Benzinga)
07:05AM	GSK and SCYNEXIS Announce an Exclusive Agreement to Commercialise and Further Develop Brexafemme (ibrexafungerp), a Novel, First-in-Class Medicine to Treat Fungal Infection (GlobeNewswire)
Mar-29-23 07:00AM	3 International Stocks With Strong Dividends and Long-Term Growth Potential (TheStreet.com)
Mar-27-23 06:21PM	Phase III RUBY clinical trial demonstrates potential of Jemperli (dostarlimab-gxly) plus chemotherapy to redefine the treatment of primary advanced or recurrent endometrial cancer versus chemotherapy alone (PR Newswire)
11:15AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Mar-26-23 08:45AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Mar-24-23 06:23AM	UPDATE 3-GSK loses bid to keep experts out of upcoming Zantac trial (Reuters)
Mar-20-23 09:54AM	Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case' (Benzinga)
Mar-17-23 01:01PM	3 Pharma Stocks That Could Benefit from Global Healthcare Trends (InvestorPlace)
08:45AM	Better RSV Vaccine Stock: Pfizer, GSK, or Moderna? (Motley Fool)
Mar-14-23 04:42PM	Johnson & Johnson: Creating Shareholder Value (GuruFocus.com)
12:00PM	GSK and Earvin "Magic" Johnson Partner to Raise Awareness of Risk of RSV in Older Adults (Business Wire)
Mar-11-23 07:15AM	3 High Dividend Healthcare Stocks for Passive Income (TheStreet.com)
Mar-10-23 03:11PM	3 High Dividend Stocks With Attractive Total Return Potential (InvestorPlace)
Mar-08-23 10:02AM	Protagonist Therapeutics (PTGX) Soars 51.9%: Is Further Upside Left in the Stock? (Zacks)
Mar-05-23 08:30AM	Could This Be the Next Blockbuster Vaccine for This Big Pharma Stock? (Motley Fool)
07:30AM	As Covid Threat Weakens, This Biotech Is Still Worth a Shot (TheStreet.com)
Mar-04-23 08:19AM	13 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds (Insider Monkey)
Mar-02-23 08:15AM	FDA Fuels Respiratory Syncytial Virus Vaccine Race While Backing GSK's Candidate Soon After Pfizer's (Benzinga)
Mar-01-23 03:05PM	UPDATE 2-US panel backs GSK vaccine, heating up RSV vaccine race (Reuters)
02:47PM	US panel backs GSK vaccine, heating up RSV vaccine race (Reuters)
Feb-28-23 05:55PM	FDA panel narrowly backs Pfizers RSV vaccine for older adults (MarketWatch)
05:21PM	FDA panel narrowly backs Pfizer RSV vaccine for older adults (AP Finance)
Feb-24-23 02:55PM	GSK's Relief For Few Months, First Trial Claiming Zantac Caused Cancer Pushed Into Late 2023 (Benzinga)
10:10AM	UPDATE 1-First Zantac cancer risk trial in Calif. postponed five months (Reuters)
Feb-23-23 06:18PM	First Zantac cancer risk trial in Calif. postponed by months (Reuters)
10:43AM	GSK/Pfizer-Backed ViiV Healthcare's HIV Treatment At Par With Gilead's: Study Shows (Benzinga)
Feb-21-23 10:15AM	My 3 Biggest Stock Market Predictions for March (Motley Fool)
Feb-16-23 06:17PM	UPDATE 1-Judge weighs key evidence ahead of first Zantac cancer trial (Reuters)
02:38PM	Judge to weigh key evidence ahead of first Zantac cancer trial (Reuters)
Feb-14-23 08:19AM	Vir Biotech To Work On Next-Gen COVID-19 Solutions Independently, Or With Other Partners, As GSK Walks Out (Benzinga)
Feb-12-23 07:31PM	11 Most Profitable European Stocks (Insider Monkey)
Feb-10-23 09:34AM	FDA AdComm Votes In Favor Of GSK's Jemperli Single Arm Trial Plan For Rectal Cancer Setting (Benzinga)
08:55AM	FDA Grants Complete Approval For GSK's Jemperli For Endometrial Cancer (Benzinga)
07:24AM	Analyst Report: GSK PLC (Argus Research)

GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GSK | GSK plc

Upgrade your FINVIZ experience